Eli Lilly & Co. will introduce two new authorized generic versions of its Humalog KwikPens (insulin lispro) in April as it grapples with ongoing public criticism over the price of its flagship insulin brand.
The launch comes as patients in high deductible insurance plans face paying the full list price for insulin as their...